Nerium Biotechnology
San Antonio · Founded 2006
About Nerium Biotechnology
Nerium Biotechnology, Inc., a biotechnology company, engages in the development of oleander-based products for the treatment of certain forms of proliferative diseases and viral infections. Its lead product includes Anvirzel, which is used to treat various forms of cancer. The company’s product line also comprises HIviral for the treatment of HIV/AIDS; HEP-viral for the treatment of hepatitis C; and NeriumAD, a skin cream for age-defying treatment. Nerium Biotechnology, Inc. is based in San Antonio, the United States.
Company Facts
- Founded: 2006
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $288.5K
- Last round: Series Unknown (Mar 2011)
- Website: nbiresearch.com
- Phone: 210-822-7908
Social Profiles
Canonical: https://fsome.com/organization/nerium-biotechnology-8371149 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.